Baxter’s Board of Directors Declares Quarterly
Shareholders Re-Elect Four Directors, Reappoint Audit Firm and Support Proposal on Simple Majority
Voting at Company’s Annual Meeting
May 04, 2010 04:35 PM Eastern Daylight Time
DEERFIELD, Ill.--(EON: Enhanced Online News)--The Board of Directors of Baxter International Inc.
(NYSE:BAX) today announced a quarterly dividend and the results of votes taken at the company’s Annual
Meeting of Shareholders held earlier today.
Baxter’s Board of Directors declared a quarterly dividend of $0.29 per share of Baxter common stock. This
payment represents a continuation of the current rate, which the company increased 12 percent earlier this year. The
quarterly dividend is payable on July 1, 2010 to shareholders of record as of June 10, 2010.
At its Annual Meeting of Shareholders held today, Baxter shareholders re-elected four members of the company’s
Board of Directors – Blake E. Devitt, John D. Forsyth, Gail D. Fosler and Carole J. Shapazian -- for a term of three
years. Shareholders also ratified the appointment of PricewaterhouseCoopers LLP as the independent registered
public accounting firm for Baxter, and voted in favor of a shareholder proposal regarding simple majority voting. The
company will evaluate next steps in implementation of the proposal.
A webcast replay of Baxter's Annual Meeting of Shareholders can be accessed from a link on the company's
website at www.baxter.com. Please visit Baxter's website for more information regarding this and future investor
events and webcasts.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain
the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic
and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of
expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient ca